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Simple Pulmonary Eosinophilia
Evaluated by Means of FDG PET: the
Findings of 14 Cases
Objective: We wanted to describe the findings of simple pulmonary eosinophil-
ia with using 18 fluorodeoxyglucose (FDG) positron emission tomography (PET).
Materials and Methods: We analysed the findings of 14 patients who under-
went thoracic computed tomography (CT) and PET, and then they were subse-
quently proven to have simple pulmonary eosinophilia. PET studies were per-
formed in four patients with malignancy to evaluate for cancer metastasis, and
PET scans were also done in 10 healthy subjects who underwent volunteer can-
cer screening. The PET scans were evaluated by using the maximum standard-
ized uptake values (SUVs). The subjects’ CT findings also were reviewed and
correlated with the PET findings.
Results: A total of 42 nodules were detected on the CT scans. There were sin-
gle nodules in three patients and multiple nodules in 11 patients (mean number of
nodules: 3, range: 1 10, mean diameter: 9.5 mm 4.7). Twelve of 42 (28.6%)
nodules showed FDG uptake and their mean maximum SUV was 2.5 1.6
(range: 0.6 5.3). Five of six solid nodules showed FDG uptake (2.2 1.1, range:
0.9 3.6), six of 11 semisolid nodules showed FDG uptake (3.1 1.8, range: 0.6-
5.3) and one of 25 pure ground-glass opacity nodule showed a maximum SUV of
0.8. The maximum SUVs of seven nodules in five patients were greater than 2.5.
The maximum SUVs were significantly different according to the nodule types (p
< 0.001).
Conclusion: Simple pulmonary eosinophilia commonly causes an increase in
FDG uptake. Therefore, correlation of the PET findings with the CT findings or the
peripheral eosinophil counts can help physicians arrive at the correct diagnosis of
simple pulmonary eosinophilia.
he recent advances in positron emission tomography (PET) with using 2-
deoxy-2-fluoro-[F-18]-D-glucose (FDG) have made a significant contribu-
tion for differentiating between benign and malignant pulmonary
diseases. However, FDG accumulation is not specific for just malignancies because
there are many causes of FDG uptake in benign tissue. As the results, increased FDG
uptake in such lesions as benign tumors or in inflammatory processes leads to false-
positive results and the misdiagnosis of malignancies. High FDG uptake has been
observed in many infectious and inflammatory conditions including histoplasmosis,
tuberculosis, blastomycosis, cryptogenic organizing pneumonia, sarcoidosis, silicosis
and etc (1 7). 
Simple pulmonary eosinophilia is also known as Loeffler’s syndrome, and it is an
acute pulmonary eosinophilia that shows characteristic clinical and radiological
changes (8). In most cases, only limited investigations are done because the clinical
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Tmanifestations are usually minimal. Along with the
development of modern diagnostic technology, we
frequently encounter the incidental detection of simple
pulmonary eosinophilia during the metastasis work-up of
cancer patients and also during cancer screening in those
healthy subjects who are without a previous history of
cancer (9). To the best of our knowledge, there has been
no study to describe the PET findings of simple pulmonary
eosinophilia. The purpose of this study was to describe the
findings of simple pulmonary eosinophilia with using FDG
PET.
MATERIALS AND METHODS
Subjects
Between May 2003 and April 2005, 14 consecutive
patients (10 men and four women, mean age: 52 years, age
range: 35 75 years) who underwent thoracic CT and
whole body PET and who were subsequently proven to
have simple pulmonary eosinophilia were included in this
study. Approval from the institutional review board was
not needed for reviewing radiologic and PET images at our
institute. The diagnosis of simple pulmonary eosinophilia
was made based on the diagnostic criteria defined by Allen
et al. (8); a) migratory pulmonary abnormalities on CT, b)
increased peripheral blood eosinophils, c) minimal or no
pulmonary symptoms, and d) spontaneous resolution
within one month.
The PET scans were performed in four patients who
were suffering with malignancy to evaluate for metastasis,
and PET scans were performed in 10 healthy subjects who
underwent voluntary cancer screening. We perform FDG
at our institution PET for two different purposes: as an
evaluation for metastasis in cancer patients and as a
cancer-screening procedure for presumptively healthy
subjects who had no previous history of malignancy and
they volunteered for this program.
FDG PET Examination and Evaluation
Positron emission tomography scans were obtained on a
dedicated whole body PET scanner (ADVANCE, GE
Medical Systems, Milwaukee, WI). All the patients had
fasted, except for water, for at least 6 hours before the PET
studies. The blood glucose levels at the time of injection
were less than 6.5 mmol/L for all the patients. Image
acquisition for the whole body scanning started about 60
min after the intravenous administration of 370 666 MBq
(10 15 mCi) FDG. Five bed positions were examined for
5 min at each step for the whole body emission scans, and
the post-injection transmission scans were followed with 3
min/steps. The emission tomographic images were
reconstructed using the iterative ordered subsets expecta-
tion maximization algorithm. The segmented attenuation
correction was performed using the transmission images.
Thoracic CT scans were used to localize the abnormality
before PET was performed. A qualified nuclear medicine
physician (S.K.K. and K.W.K) who were well experienced
with CT findings interpreted the PET scans. The maximum
standardized uptake value (SUV) that was obtained by
selecting a small region of interest (ROI) was used in the
analysis. Partial volume correction was not done. The
SUVs were calculated based on the following equation:
SUV = tissue concentration (MBq/g)/[injected dose
(MBq)/body weight(g)] (9). 
Thoracic CT Examination and Evaluation 
The CT examinations were performed by using a four-
channel multi-detector row CT scanner (MX8000; Philips
Medical Systems, Cleveland, OH). CT scans were
performed for the four patients with malignancy to
evaluate for metastasis. Scanning was performed in a
caudocrainal direction by using 10-mm nominal collima-
tion (4 2.5 mm), with an effective section width of 3.2
mm, a gantry rotation speed of 0.5 seconds, a table speed
of 20 mm/sec, a pitch of 1, a tube voltage of 120 kV and a
tube current of 200 300 mAs. Each examination was
reconstructed with a 3 mm interval. Iopromide, 100 mL
(Ultravist 370; Schering, Berlin, Germany) was injected
intravenously in all four patients. Low-dose screening CT
scans were performed in the 10 healthy subjects who
underwent voluntary cancer screening. The scanning was
performed with the same protocols as that of conventional
CT scans except for low mAs (25 30 mAs). No
intravenous contrast material was used in the low-dose
screening CT.
All the patients underwent initial CT and FDG PET
within a maximum of four days of each other, and they
had received no any medical treatment. Follow-up CT to
confirm any spontaneous resolution of their pulmonary
lesions was performed with intervals ranging from 7 days
to 28 days (mean: 15.5 days 12.0). Two thoracic radiolo-
gists (T.J.K. and H.Y.K.) assessed all the CT images by
working in consensus. The number, location, size and
characteristics of each lesion were recorded. The
pulmonary nodules were categorized into three groups
according to the nodule characteristics: solid nodule,
semisolid nodule and pure ground-glass opacity nodule. 
Statistical Analysis
The SPSS software package version 10.0 (SPSS,
Chicago, IL) was used for the statistical data analysis. The
number of nodules and the maximum SUV in each patient
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of Spearman’s rank correlation coefficient. The differences
in the nodule size and the maximum SUV among the three
groups, according to the nodule characteristics, were
evaluated by the Kruskal-Wallis test. For all tests, a p value
less than 0.05 was used to indicate significance.
RESULTS
The PET scans were performed in four patients who had
different malignancies to evaluate for metastasis; rectal
cancer (n = 1), esophageal cancer (n = 2) and synovial
sarcoma (n = 1). All four patients receive no medical
treatment while the CT or PET scans were performed. The
ten healthy subjects who underwent voluntary cancer
screening had no current associated diseases. All the
subjects had no specific respiratory symptoms.
A total of 42 nodules were detected on the CT scans.
There were single nodules in three patients and multiple
nodules in 11 patients (mean number of nodules: 3.1,
range of the number of nodules: 1 7). The nodules were
categorized into three groups according to the nodule
characteristics seen on CT; solid nodule (n = 6) (Fig. 1),
semisolid nodule (n = 11) (Figs. 1 3) or pure ground-glass
opacity nodule (n = 25). The means of the longest nodule
diameter of each group were 10.7 mm  3.8 (standard
deviation: SD) (range: 5 15 mm), 8.6 mm  4.4 (SD)
(range: 3 20 mm) and 10.8 mm  5.8 (SD) (range: 3 20
mm), respectively. There was no significant difference in
nodule size among each group (p = 0.357; Kruskal-Wallis
test). On the follow-up CT scans, all the nodules showed
complete resolution and new nodules were found in four
patients. 
Twelve of 42 (28.6%) nodules showed FDG uptake on
the PET scans, and the mean maximum SUV was 2.5 1.6
(SD) (range: 0.6 5.3). Five of the six (83.3%) solid
nodules showed FDG uptake (2.2 1.1, range: 0.9 3.6)
(Fig. 1), six of the 11 semisolid nodules (54.5%) showed
FDG uptake (3.1 1.8, range: 0.6 5.3) (Figs. 1 3) and
one of the 25 (4%) pure ground-glass opacity nodules
showed a maximum SUV of 0.8. The maximum SUVs of
seven nodules in five patients were greater than 2.5. The
means of the maximum SUVs of each group were 1.9
1.4, 1.7  2.1 and 0.03 0.1, respectively. When the
maximum SUVs were compared among the three groups,
there was a significant difference between the nodule types
and maximum SUVs (p < 0.001; Kruskal-Wallis test). 
The means of the percentages and the absolute values of
the eosinophils of the patients were 12.1% (range: 6.6
22) and 884 cells/mm
3 (range: 576 1,469), respectively.
The maximum SUVs and the number of nodules had no
significant positive correlation with the corresponding
eosinophil counts (r = 0.206, p = 0.480; r = 0.226, p =
0.437, respectively). 
DISCUSSION
Simple pulmonary eosinophilia is an acute pulmonary
eosinophilia that shows characteristic clinical and
radiologic changes (8). The patients typically have few or
no symptoms, and the diagnosis is often initially suspected
by the characteristic findings on the chest radiographs or
the CT scans. The CT appearance of simple pulmonary
eosinophilia consists of patchy unilateral or bilateral
airspace consolidation with a predominantly peripheral
distribution, areas of ground-glass opacity predominantly
in the middle and upper lung zones and there can be
multiple nodules (9, 11). 
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Fig. 1. Simple pulmonary eosinophilia in a 61-year-old man with rectal cancer that mimicked metastasis on both the CT and PET. 
A. Transverse CT scan obtained with the lung window setting shows two round nodules in the right lower lobe (arrow) and the left upper
lobe (arrowhead). 
B. The transverse FDG PET scan shows increased uptake in the nodules with an SUV of 5.3 (arrow) and 3.0 (arrowhead), respectively.
The nodules showed complete resolution on the follow-up CT scans performed 2 weeks later (not shown).
ABNumerous reports have demonstrated increased FDG
uptake at the site of infection and inflammation. FDG is
incorporated into acute inflammatory lesions that have
both acute (polymorphoneuclear) and chronic cells such as
macrophages or lymphocytes (12). The granulomatous
diseases of chronic infections usually demonstrate signifi-
cant levels of FDG uptake, and these levels can overlap
with the levels noted for malignant diseases (2, 3). This
overlap in the uptake levels can pose a difficulty to distin-
guish such low-grade lung malignancies as bronchioloalve-
olar carcinoma from the granulomatous infections. Several
acute inflammatory or infectious conditions such as
pneumonia or other bacterial infections have also been
associated with a relatively mild degree of FDG uptake
(13). However, to the best of our knowledge, the FDG
uptake in simple pulmonary eosinophilia has not
previously been described. The results of our study
indicate that the FDG uptake in patients is quite different
from each other according to their nodule types. A solid
nodule with or without a ground-glass opacity halo showed
a higher frequency and level of FDG uptake compared to
the pure ground-glass opacity nodule. There was no signifi-
cant difference in nodule size among each nodule group.
These results indicate that the SUV is closely related with
FDG PET Evaluation of Simple Pulmonary Eosinophilia
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Fig. 3. Simple pulmonary eosinophilia in a 65-year-old man with esophageal cancer that mimicked metastasis on both CT and PET. 
A. The transverse CT scan obtained with the lung window setting shows a ground-glass opacity nodule with a central solid portion in the
right lower lobe (arrow). 
B. The tansverse FDG PET scan shows the increased uptake in the nodule with SUV of 2.0 (arrow). 
AB
Fig. 2. Simple pulmonary eosinophilia in a 52-year-old healthy man who underwent
voluntary cancer screening. 
A. Transverse CT scan obtained with the lung window setting shows a semisolid
nodule in the left lower lobe (arrow). 
B. The coronal FDG PET scan shows the increased uptake in the nodule with an
SUV of 4.5 (arrow). 
A
Bthe density of the inflammatory cells that make up the
nodules. However, it is interesting to note that the
eosinophil count in the peripheral blood itself did not show
positive correlation with the maximum SUVs or the
number of nodules.
Patients with simple pulmonary eosinophilia do not need
any treatment because this condition resolves sponta-
neously within one month. In most cases, only limited
investigations are done because the clinical manifestations
are minimal. With the development of such modern
diagnostic technology as CT, we frequently encounter the
incidental detection of simple pulmonary eosinophilia
during the metastasis work-ups of cancer patients and
during cancer screenings for healthy subjects. The clinical
significance of the detection of simple pulmonary
eosinophilia lies in the distinction from such malignancies
as bronchioloalveolar carcinoma or well-differentiated
adenocarcinoma and metastasis. 
Bronchioloalveolar carcinoma and well-differentiated
adenocarcinoma commonly appear as a solitary pulmonary
nodule that is associated with ground-glass opacity. The
area of ground-glass opacity reflects the histopathologi-
cally, that is, a unique lepidic growth pattern in which the
tumor spreads into the distal air spaces by using the
alveolar septa as a stroma (14). Pulmonary nodules with
ground-glass opacity halos can also be frequently seen in
patients with simple pulmonary eosinophilia; a halo of
ground glass opacity results from pulmonary infiltrations of
eosinophils and other inflammatory cells (8, 9, 11, 20).
These two different conditions can show similar findings on
both CT and FDG PET.
Nomori et al. showed that FDG PET had false positive or
false negative findings more frequently for the ground-
glass opacity nodules than for the solid ones (15). In their
study, nine of 10 well-defined adenocarcinomas with
ground-glass opacity halos were negative on FDG PET.
However, four of five active inflammatory nodules with
ground-glass opacity halos were positive on FDG PET.
These false negative and positive results are due to the low
glucose metabolism of well-differentiated adenocarcinoma
and the high glucose metabolism of nodules with active
inflammation, respectively (16-18). These results suggest
that the FDG PET results should be interpreted in
combination with the CT findings when differentiating
benign from malignant pulmonary nodules with ground-
glass opacity. 
Multiple nodules, which are common in simple
pulmonary eosinophilia, also lead to a diagnostic dilemma
when differentiating them from metastasis. In our study, all
four patients with malignancy had multiple pulmonary
nodules that mimicked metastasis. The two nodules in a
patient with rectal cancer showed high SUVs of 5.3 and
3.0, respectively, and this strongly suggests the possibility
of metastasis (Fig. 1). Our results suggest that positive FDG
PET results should be interpreted with caution when differ-
entiating benign from malignant nodules, and especially in
those patients with an underlying malignancy. CT findings
such as ground-glass opacity halo around the nodule or
peripheral eosinophilia may be helpful in differentiating
metastasis from simple pulmonary eosinophilia.
It is well known that inflammatory cells have a high
glucose metabolism when they are activated via infection
or inflammation (19). Pathologically, eosinophils and
histiocytes accumulate in the alveolar spaces and walls in
simple pulmonary eosinophilia (20). It may be considered
that the eosinophils and histiocytes in inflammatory tissue
use glucose as an energy source for chemotaxis and
phagocytosis.
Our study had several limitations. First, we included only
a small number of patients. Second, because our study is a
retrospective study, we could not suggest the incidence of
FDG uptake of simple pulmonary eosinophilia in both
cancer patients and healthy subjects. Another limitation is
the lack of any pathologic correlation in our patients.
However, because of its benign and transient nature, the
diagnosis of simple pulmonary eosinophilia in daily clinical
practice is exclusively based on the clinical course and
imaging studies. 
In conclusion, simple pulmonary eosinophilia commonly
causes an increase in FDG uptake. Therefore, correlation
of the PET findings with the CT findings or with the
peripheral eosinophil counts may help physicians to arrive
at the correct diagnosis of simple pulmonary eosinophilia. 
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